Skip to main content
Harbin Pharmaceutical Group Co.,Ltd. logo

Harbin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 600664 ISIN · CNE0000009T3 LEI · 300300G0L086UJ23MI26 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,827 across all filing types
Latest filing 2020-04-22 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600664

About Harbin Pharmaceutical Group Co.,Ltd.

https://www.hayao.com/

Harbin Pharmaceutical Group Co., Ltd. specializes in the research, development, manufacture, and distribution of a diverse range of pharmaceutical and healthcare products. The company's portfolio includes antibiotics, over-the-counter (OTC) medicines, health supplements, traditional Chinese medicines, and animal health products. It operates through several specialized subsidiaries and maintains a significant presence in the production of penicillins and cephalosporins. A key strategic focus involves the health and nutrition sector, bolstered by the acquisition of global nutrition brand GNC. The company leverages large-scale manufacturing capabilities and an extensive distribution network to serve both domestic and international markets. Its operations emphasize technological innovation and quality control across its integrated supply chain, from raw material production to finished dosage forms.

Recent filings

Filing Released Lang Actions
独立董事关于公司2020年日常关联交易预计的独立意见
Board/Management Information Classification · 90% confidence The document is an independent director's opinion on the company's 2020 daily related-party transactions. It references compliance with company law, stock exchange listing rules, and internal governance documents. The content is a formal opinion letter rather than a full report or announcement of voting results. It does not contain financial statements or detailed financial data, nor is it a certification or a brief announcement. It is a governance-related document expressing an independent director's approval of related-party transactions, which fits best under Board/Management Information (MANG) as it relates to board oversight and governance matters.
2020-04-22 Chinese
公司章程（2020年4月修订版）
Governance Information Classification · 100% confidence The document is titled "章程" which translates to "Articles of Association" or "Company Bylaws". It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, share issuance, shareholder meetings, voting procedures, and other governance-related rules. The content is focused on the internal rules and governance framework of the company rather than financial performance, audit results, or meeting announcements. There is no indication that this is an announcement or a summary of a meeting, nor is it a financial report or earnings release. The document is comprehensive and legalistic, consistent with a governance document outlining the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR).
2020-04-22 Chinese
股东回报规划（2020年-2022年）
Notice of Dividend Amount Classification · 95% confidence The document is a detailed plan outlining the company's shareholder return policy for the years 2020 to 2022. It discusses profit distribution policies, conditions for cash dividends and stock dividends, proportions of profit distribution, decision-making procedures, and mechanisms for revising the plan. It references regulatory guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange, as well as the company's articles of association. The document is not a financial report, earnings release, or announcement of voting results. It is a policy document related to dividend and shareholder return planning, which fits best under the category of Notice of Dividend Amount (DIV) because it details the company's dividend distribution policy and plans for shareholder returns over a multi-year period. The document length is 3332 characters, which is substantive and contains detailed policy information rather than a brief announcement or a report publication notice. Therefore, the most appropriate classification is DIV with high confidence.
2020-04-22 Chinese
八届二十八次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from 哈药集团股份有限公司 dated April 2020. It details the approval of the 2019 annual report, board work report, independent directors' report, audit committee report, audit summary, financial budget, internal control reports, asset impairment provisions, profit distribution proposal, and other corporate governance matters. The document repeatedly states that the full reports are disclosed separately on the Shanghai Stock Exchange website, indicating this document itself is not the full annual report but a board meeting resolution summary. The document length is about 3,038 characters, which is relatively short and mainly announces decisions and references other detailed reports. This fits the category of Board/Management Information (MANG), as it announces board meeting resolutions and management decisions rather than providing the full annual report or audit report. Therefore, the correct classification is MANG with high confidence.
2020-04-22 Chinese
董事会审计委员会2019年度履职报告
Audit Report / Information Classification · 95% confidence The document is titled as the "Board Audit Committee 2019 Annual Performance Report" of Harbin Pharmaceutical Group Co., Ltd. It details the audit committee's activities during 2019, including meetings held, evaluation of external auditors, review of financial reports, internal audit guidance, and internal control assessments. The document is a report on the audit committee's duties and oversight related to auditing and internal controls for the year 2019. It is not the full annual report or audit report itself but a committee's performance report related to audit functions. This fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related information about audit activities and internal controls, excluding full annual reports. The document length is 2536 characters, which is sufficient for a detailed committee report but not a full annual report. Therefore, the classification is AR with high confidence. FY 2019
2020-04-22 Chinese
2019年度财务报表审计报告
Audit Report / Information Classification · 95% confidence The document is titled '年度财务报表审计报告' which translates to 'Annual Financial Statement Audit Report'. It includes detailed audit opinions, audit basis, key audit matters, and extensive financial statements such as consolidated balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a standalone audit report prepared by an accounting firm, focusing on the audit of the annual financial statements for the fiscal year ending December 31, 2019. It does not appear to be the full annual report (10-K) but rather the audit report and related financial statements. Therefore, the appropriate classification is Audit Report / Information (AR).
2020-04-22 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.